Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Niedermann

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Journal of Cancer Research and Clinical Oncology|January 27, 2024
Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphomaLaduona Wang, Yue Zheng, Ren Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal EffectRen Luo, Kateryna Onyshchenko, Liqun Wang, et al.
Nature Communications|August 5, 2024
Author Correction: Expansion of circulating stem-like CD8<sup>+</sup> T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in miceKateryna Onyshchenko, Ren Luo, Elena Guffart, et al.
Nature Communications|April 12, 2023
Expansion of circulating stem-like CD8<sup>+</sup> T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in miceKateryna Onyshchenko, Ren Luo, Elena Guffart, et al.
Human Gene Therapy|May 1, 2018
Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T CellsBian Hu, Yan Zou, Linlin Zhang, et al.
Signal Transduction and Targeted Therapy|May 21, 2024
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunitiesNanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Cancer Research|December 4, 2002
Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysisSimone Gaedicke, Elke Firat-Geier, Oana Constantiniu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Analysis of direct and cross-presentation of antigens in TPPII knockout miceElke Firat, Jisen Huai, Loredana Saveanu, et al.
Theranostics|April 22, 2024
Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor modelsKateryna Onyshchenko, Ren Luo, Xi Rao, et al.
Theranostics|May 11, 2016
Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific AntibodiesHua Jing, Claudia Weidensteiner, Wilfried Reichardt, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Journal of Cancer Research and Clinical Oncology|January 27, 2024
Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphomaLaduona Wang, Yue Zheng, Ren Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal EffectRen Luo, Kateryna Onyshchenko, Liqun Wang, et al.
Nature Communications|August 5, 2024
Author Correction: Expansion of circulating stem-like CD8<sup>+</sup> T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in miceKateryna Onyshchenko, Ren Luo, Elena Guffart, et al.
Nature Communications|April 12, 2023
Expansion of circulating stem-like CD8<sup>+</sup> T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in miceKateryna Onyshchenko, Ren Luo, Elena Guffart, et al.
Human Gene Therapy|May 1, 2018
Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T CellsBian Hu, Yan Zou, Linlin Zhang, et al.
Signal Transduction and Targeted Therapy|May 21, 2024
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunitiesNanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Cancer Research|December 4, 2002
Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysisSimone Gaedicke, Elke Firat-Geier, Oana Constantiniu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Analysis of direct and cross-presentation of antigens in TPPII knockout miceElke Firat, Jisen Huai, Loredana Saveanu, et al.
Theranostics|April 22, 2024
Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor modelsKateryna Onyshchenko, Ren Luo, Xi Rao, et al.
Theranostics|May 11, 2016
Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific AntibodiesHua Jing, Claudia Weidensteiner, Wilfried Reichardt, et al.
Pageof 8